The CDSCO plans to strengthen monitoring of medicines containing narcotic and psychotropic substances to prevent illegal diversion. Proposed measures include monthly state-wise reporting on licences, drug quantities, inspections and enforcement actions, along with a common digital platform for tracking controlled medicines across the supply chain.